Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 13 results found. Search for [ Heather Bresch ]

Results 1 to 13 of 13
November 18, 2019
The significant violations included failure to have adequate written procedures for the receipt, identification, testing and handling of raw materials

December 2, 2017
Ogivri is the first United States Food and Drug Administration (USFDA) approved biosimilar to Herceptin and the first biosimilar from Mylan and Biocon's joint portfolio approved in the US, the two companies said in a joint statement.

Ajay Kapur
October 12, 2015
The idea of CSR and Sustainability reporting, introduced in the Companies Act, today provides financial value besides driving innovation, reinforcing the old adage of \"what gets measured gets managed\".

PB Jayakumar
October 9, 2015
Mylan CEO Heather Bresch says India has been doing a pretty good job with its tax-free development zones. Your CSR model is something the rest of the world should follow. It is a great thing to give back to the country, especially when you are developing.

PB Jayakumar
October 1, 2015
In 2014, the Office of Manufacturing Quality had given only five warning letters to Indian companies out of a total of 19 issued. At the receiving end last year were firms like Cadila Pharmaceuticals, Marck Biosciences, Sun Pharma, Smruti Organics and USV Limited.

Sarika Malhotra
September 19, 2015
Business Today showcased the rapid strides made by women in corporate India at a glittering ceremony in Mumbai.

Team BT
Mumbai, September 11, 2015
Among the winners was, India's richest woman, Nita Ambani, the Chairman of Reliance Foundation and Director of Reliance Industries.

September 10, 2015
\"Nooyi marks her ninth year atop the $66.6 billion snack-and-drink behemoth in a stronger position than she's been in for a long time,\" Fortune said about the 59-year-old top executive.

New Delhi, August 19, 2015
The US regulator said its inspectors found significant violations in the three manufacturing facilities in Bengaluru, which is an arm of US-based Mylan Inc. Of the three units, two plants belonged to Agila Specialties, which Mylan had acquired from Strides Arcolab in 2013-end. The other unit is owned by Mylan Laboratories.

E Kumar Sharma
May 27, 2015
Mylan is strongly resisting an unsolicited $40 billion bid by Israel-based Teva to acquire Mylan. But on the other hand, it is also pursuing its own $32.7 billion bid to acquire Ireland-based maker of cough and cold remedies.

New Delhi, February 2, 2015
The deal envisages payment of $750 million in cash plus additional contingent payments of up to $50 million.

E. Kumar Sharma
May 31, 2014
In the seven years since, Mylan Inc has invested around $3 billion on acquisitions in India. It now regards India not just as a global sourcing hub, but also as a market.
March 25, 2013
Generic drugmaker Mylan Inc. will acquire Agila Specialties - a developer, manufacturer and marketer of high-quality generic injectible products - from Strides Arcolab for $1.6 billion (Rs 8,674.2 crore) in cash.